FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a composition for the treatment of opisthorchosis. Composition based on praziquantel for the treatment of opisthorchosis, including the complex of praziquantel and the sodium salt of the plant saponin – glycyrrhizinic acid with the mass ratios of the components of praziquantel: sodium salt of glycyrrhizinic acid, respectively, 1:5–20, obtained by joint mechanical activation of the mixture of the starting components.
EFFECT: above described composition can be used for the effective treatment of opisthorchosis at lower dosages of the active substance without toxic side effects, since it possesses enhanced anti-opisthorchid flukes action and reduced toxicity.
1 cl, 8 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ALBENDAZOLE-BASED COMPOSITION WITH ANTI-OPISTHORCHOSIS PHARMACOLOGICAL ACTIVITY | 2013 |
|
RU2545797C1 |
| AGENT POSSESSING ANTIOPISTHORCHIASIS ACTIVITY | 2019 |
|
RU2702733C1 |
| AGENT FOR PREVENTING OPISTHORCHIASIS INFECTION | 2018 |
|
RU2703296C1 |
| PREPARATION FOR THE TREATMENT OF FISH WITH HELMINTHIASES | 2018 |
|
RU2681946C1 |
| METHOD OF COMPLEX TREATMENT OF PATIENTS WITH PARASITIC DISEASES | 2011 |
|
RU2491936C2 |
| AGENT FOR PREVENTING AND TREATING HELMINTHIASIS, PARTICULARLY OPISTHORCHIASIS | 2011 |
|
RU2493864C2 |
| DRUG FOR ANIMAL HELMINTHOSIS TREATMENT | 2016 |
|
RU2635514C1 |
| ANTHELMINTIC DRUG FROM THE GROUP OF BENZIMIDAZOLES | 2022 |
|
RU2798619C1 |
| ANTIPARASITIC AGENT BASED ON ALBENDAZOLE AND METHOD OF ITS USE FOR TREATMENT OF HELMINTHOSES OF MAMMALS | 2014 |
|
RU2546535C1 |
| COMPOSITION BASED ON R(-)-PRAZIQUANTEL FOR TREATING AND PREVENTING HELMINTHIASIS IN WARM-BLOODED ANIMALS | 2015 |
|
RU2613490C2 |
